Sub Banner Image

Is Pfizer Stock Underperforming the Nasdaq?

Equities

Neharika Jain

·

September 2, 2025

·

Barchart

Although Pfizer has underperformed the Nasdaq recently, analysts remain moderately optimistic about the stock’s prospects.

More from

Barchart

More

Equities

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.